Mirum Pharmaceuticals, Inc. (08D)
Market Open
22 Oct, 03:31 PM
XETRA XETRA Primary €
74. 40
-0.5
-0.6676%
€
- Market Cap
- P/E Ratio
- Div Yield
18 Volume
-3.47 Eps
€ 74.9
Previous Close Want to track 08D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mirum Pharmaceuticals, Inc. (08D) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.56B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue 8.27
Enterprise Value/EBITDA -72.69
Overview
Shares outstanding -
Float 56.4M
Shares short -
% Held by insiders 0.01%
% Held by institutions 1.12%
Average volume (10 days) 30
Average volume (90 days) 93
Price summary
52-Week low 70.54
52-Week high 113.2
Beta 0.61
50-Day moving average 81.45
200-Day moving average 87.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.39%
Operating margin -0.15%
Operational effectiveness
Return on assets -0.07%
Return on equity -7.03%
Income Statement
Revenue (ttm) 552.09M
Revenue per share (ttm) 11.02
Quarterly revenue growth (yoy) 0.38%
Gross profit (ttm) 451.2M
EBITDA -62.78M
Net income to common (ttm) -768.39M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 391.51M
Total cash per share (mrq) 6.75
Total debt (mrq) 681.51M
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.86%
Book value per share (mrq) -0.14
Cash Flow
Cash flow statement -203.01M
Levered free cash flow (LFCF) 68.44M
2026 © Marketlog. All Rights Reserved.
